The View on GU with Lalani & Wallis

  • Home
  • The View on GU with Lalani & Wallis

The View on GU with Lalani & Wallis A new podcast developed by clinicians for clinicians, focused on optimizing multi-disciplinary healthcare within the field of genitourinary cancers.

There is currently a lack of organic multi-disciplinary discussion on what is truly impactful to the field of genitourinary (GU) cancers. The View on GU with Lalani & Wallis is a podcast that will integrate key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians. Importantly, Lalani and Wallis will also discuss the impact o

f governmental approvals and funding considerations on the GU oncology treatment landscape and provide practical considerations on the management of patients on new-to-market therapies. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.

Dropping this Thursday: one of our most insightful career conversations yet! ✨ Episode 33 features Dr. Daniel Heng, Clin...
15/12/2025

Dropping this Thursday: one of our most insightful career conversations yet! ✨ Episode 33 features Dr. Daniel Heng, Clinical Professor at the University of Calgary and Head of Medical Oncology at the Arthur J.E. Child Comprehensive Cancer Centre.

Dr. Heng joins your hosts Dr. Aly-Khan Lalani and Dr. Christopher Wallis to reflect on the origins of the IMDC (born during a Boxing Day snowstorm!) and the pivotal role mentorship and sponsorship have played throughout his career. Don’t miss this exciting conversation about career guidance, community vs academic pathways, and more.

Learn more about The View on GU: www.theviewongu.com and the IMDC: www.imdconline.com

13/11/2025

From presidential sessions to pragmatic trials, offered no shortage of insights.

One standout was the LenCabo study, comparing lenvatinib + everolimus with cabozantinib after IO therapy and showing a strong PFS signal. In Episode 32, Dr. Aly-Khan Lalani dives into the data, calling it “a tease for what we’d want to see in a future trial.”

Catch this discussion, and the full ESMO - European Society for Medical Oncology 2025 Recap Series covering bladder, prostate, and kidney cancer, at theviewongu.com

10/11/2025

Lutetium-PSMA stole the spotlight with its own presidential at ! 🌟The highly publicized PSMAddition trial presented by Scott Tagawa is broken down by your hosts Dr. Aly-Khan Lalani and Dr. Christopher Wallis in Episode 31.

Tune in to hear their expert insights! Discover how these results could expand the theranostic paradigm and impact men with metastatic castration-sensitive prostate cancer. Watch or listen now: https://theviewongu.com

ESMO - European Society for Medical Oncology

06/11/2025

Didn’t have time to take in all the updates from ? 🤔

Join Dr. Aly-Khan Lalani and Dr. Christopher Wallis for their three-part ESMO - European Society for Medical Oncology 2025 Recap Series, where they unpack the most important findings across bladder, prostate, and kidney cancer.

From reviewing IMvigor011 in Episode 30 to the latest in RAMPART and ENZARAD in Episodes 31 and 32, your hosts break down the data, provide the context, and highlight the key takeaways.

Watch or listen now: theviewongu.com

03/11/2025

At , the highly anticipated RAMPART trial results were unveiled. If you missed them, The View on GU has you covered!

In the final episode of our ESMO - European Society for Medical Oncology 2025 Recap Series, Dr. Aly-Khan Lalani and Dr. Christopher Wallis explore what RAMPART reveals about adjuvant durvalumab ± tremelimumab in resected RCC, how it fits alongside KEYNOTE-564, and the evolving role of risk-based selection tools like the Leibovich score in identifying candidates for perioperative therapy.

Watch or listen now: https://theviewongu.com

31/10/2025

brought big discussions around high-risk localized prostate cancer.

In Episode 31, Dr. Aly-Khan Lalani and Dr. Christopher Wallis unpack prostate cancer trials, including the ENZARAD trial, comparing it to STAMPEDE and what it means for the role of ARPIs in the localized setting.

Catch the full ESMO - European Society for Medical Oncology Recap Series now: theviewongu.com

30/10/2025

When Dr. Aly-Khan Lalani and Dr. Christopher Wallis sat down to record the first episode of their Recap Series on bladder cancer, the Toronto Blue Jays had just clinched the American League Championship! ⚾

Now, as the Jays return home for Game 6 of the World Series tomorrow, take a short break from baseball fever and catch up on the biggest bladder updates from Berlin and ESMO - European Society for Medical Oncology:

🔹 The evolving role of PD-1/PD-L1 inhibitors
🔹 ctDNA-guided adjuvant therapy
🔹 Antibody-drug conjugates redefining metastatic management
🔹And other key takeaways from major bladder trials

Watch or listen now: theviewongu.com

From Berlin to your ears, Dr. Aly-Khan Lalani and Dr. Christopher Wallis bring the most important highlights from   stra...
24/10/2025

From Berlin to your ears, Dr. Aly-Khan Lalani and Dr. Christopher Wallis bring the most important highlights from straight to you!

Tune in to our 2025 ESMO - European Society for Medical Oncology Recap Series launching October 28th to catch three brand-new episodes packed with the latest breakthroughs in :

🗓️ Episode 30: ESMO 2025 Commentary: Bladder Cancer
🗓️ Episode 31: ESMO 2025 Commentary: Prostate Cancer
🗓️ Episode 32: ESMO 2025 Commentary: Kidneu Cancer

Get ready for cutting-edge data, fresh trial insights, and expert takes you won’t want to miss. Learn more about The View on GU: https://theviewongu.com

📍Reporting live from Day 1 at  ! Hallo aus Berlin 🇩🇪The View on GU team is on the ground in Berlin, ready to dive into t...
17/10/2025

📍Reporting live from Day 1 at ! Hallo aus Berlin 🇩🇪

The View on GU team is on the ground in Berlin, ready to dive into the latest in .

If you missed our recent episode with Dr. Monty Pal breaking down what to expect at this year's congress, now’s the perfect time to tune in. We’ll be back soon with highlights from the conference floor!

Learn more about The View on GU: https://theviewongu.ca/

ESMO - European Society for Medical Oncology

16/10/2025

Are you en route to Berlin, Germany for ? ✈️ As you travel, watch or listen to the most recent episode of ! Episode 29 welcomes Dr. Monty Pal for a discussion about what to expect at this year’s ESMO - European Society for Medical Oncology Congress, including some important presentations.

Watch or listen now: https://theviewongu.com

15/10/2025

is just a few days away! Get the inside scoop from our brand-new episode before the conference kicks off.

In our newest episode, Dr. Aly-Khan Lalani and Dr. Chris Wallis are thrilled to welcome Dr. Monty Pal of City of Hope for what to expect from this year’s ESMO - European Society for Medical Oncology Congress.

Episode 29 is out now, so tune in for a preview of what’s ahead in Berlin, from breakthrough bladder cancer data to the newest approaches in prostate and kidney cancer. Watch or listen now: theviewongu.com

Address


Alerts

Be the first to know and let us send you an email when The View on GU with Lalani & Wallis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The View on GU with Lalani & Wallis:

  • Want your business to be the top-listed Media Company?

Share